Results of Pediatric Clinical Trial of External Trigeminal Nerve Stimulation for the Treatment of ADHDApril 18, 2013 3:01 am | by PR Newswire | News | Comments
LOS ANGELES, April 18, 2013 /PRNewswire/ -- NeuroSigma, Inc., a California-based medical device company, today announced that the results of the first-ever pediatric clinical trial of external Trigeminal Nerve stimulation (eTNS™) for the treatment of attention-deficit...
Cigarette smoking is the leading cause of preventable deaths globally. Unfortunately smoking cessation is difficult, with more than 90% of attempts to quit resulting in relapse. There are a growing number of available methods that can be tried in the effort to reduce smoking, including medications, behavioral therapies, hypnosis, and even acupuncture.
Medical device maker Boston Scientific acquired the fiXate tissue band from Anulex Technologies, launching the suturing system right away. The fiXate device is a semi-automatic suturing system designed to secure spinal cord stimulator leads and pain pump catheters, touting deployment in under 1 minute in bench testing, according to a press release.
The trickiest thing about the brain mapping project might be that we don’t even know what we’re trying to learn. Brain Research through Advancing Innovative Neurotechnologies (BRAIN) project, which President Obama announced in his State of the Union address in February, will be a decade-long effort to understand the nature of thought.
Society for Brain Mapping and Therapeutics (SBMT) announce the formation of American Board of Brain Mapping, its 2013 award recipients and its Brain Mapping Day at the US CongressApril 12, 2013 3:16 pm | by Bio-Medicine.Org | News | Comments
LOS ANGELES , April 12, 2013 /PRNewswire-USNewswire/ -- President Obama said in his April 2 nd speech "We have been a nation of dreamers and risk-takers; people who see what nobody else sees sooner than anybody else sees it. We do innovation better than anybody else -- and that makes our economy stronger. When we invest in the best ideas before anybody else does, our business...
NATICK, Mass., April 12, 2013 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has received approval by the U.S. Food and Drug Administration and is beginning a limited launch of the Precision Spectra Spinal Cord Stimulator (SCS) System. The Precision Spectra System is the...
A microscopic light-emitting diode device that controls the activity of neurons has given researchers wireless control over animal behavior. The tiny device, tested in mice, causes less damage than other methods used to deliver light into the brain, report researchers in Thursday’s issue of Science, and it does not tether mice to a light source, enabling scientists to study behaviors more naturally than is normally possible.
Medtech titan Medtronic enrolled the initial patients in its SubQStim II pivotal clinical trial, evaluating the use of peripheral nerve stimulation in treatment of chronic back pain. The new study is the latest in a handful of neurostimulation trials launched by the medical device giant as it continues to battle rivals in the market for neurostimulation systems that treat chronic pain.
For the first time, scientists have been able to predict how much pain people are feeling by looking at images of their brains, according to a new study led by the University of Colorado Boulder. The findings, published today in the New England Journal of Medicine, may lead to the development of reliable methods doctors can use to objectively quantify a patient's pain.
Functional loss of limb control in individuals with spinal cord injury or stroke can be caused by interruption of the neural pathways between brain and spinal cord, although the neural circuits located above and below the lesion remain functional. An artificial neural connection that bridges the lost pathway and connects brain to spinal circuits has potential to ameliorate the functional loss.
The sensation of having a physical body is not as self-evident as one might think. Almost everyone who has had an arm or leg amputated experiences a phantom limb: a vivid sensation that the missing limb is still present. A new study by neuroscientists at the Karolinska Institutet in Sweden shows that it is possible to evoke the illusion of having a phantom hand in non-amputated individuals.
Combining neuroscience and chemical engineering, researchers at Stanford University have developed a process that renders a mouse brain transparent. The postmortem brain remains whole — not sliced or sectioned in any way — with its three-dimensional complexity of fine wiring and molecular structures completely intact and able to be measured and probed at will with visible light and chemicals.
Talk about clearing your head: Stanford University scientists have found a way to make see-through mouse brains. You take the brain out of the mouse, soak it in chemicals for a couple of days, and voila: It becomes transparent. That's not just a parlor trick.
St. Jude Medical has announced European CE Mark approval of its Brio™, Libra™ and LibraXP™ deep brain stimulation (DBS) systems for managing the symptoms of intractable primary and secondary dystonia, a neurological movement disorder that causes a person’s muscles to contract and involuntarily spasm, reducing the ability to control movement.
Stephen Hawking toured a stem cell laboratory Tuesday where scientists are studying ways to slow the progression of Lou Gehrig's disease, a neurological disorder that has left the British cosmologist almost completely paralyzed. After the visit, the 71-year-old Hawking urged doctors, nurses and staff at Cedars-Sinai Medical Center to support the research.
Setting a mouse free to roam might alarm most people, but not so for nuclear imaging researchers from the U.S. Department of Energy’s Thomas Jefferson National Accelerator Facility, Oak Ridge National Laboratory, Johns Hopkins Medical School and the University of Maryland who have developed a new imaging system for mouse brain studies.
AdvaMed 2013 is the leading MedTech conference in North America, bringing more than 1,000 companies together in a uniquely multifaceted environment for business development, capital formation, innovative technology showcasing, world-class educational opportunities and networking.
Last week, President Obama officially announced $100 million in funding for arguably the most ambitious neuroscience initiative ever proposed. The Brain Research through Advancing Innovative Neurotechnologies, or BRAIN, as the project is now called, aims to reconstruct the activity of every single neuron as they fire simultaneously in different brain circuits, or perhaps even whole brains.
Dementia’s financial impact on the U.S. economy in 2010 was around $109 billion, reported researchers in the New England Journal of Medicine on Wednesday. That figure largely consists of the costs of nursing-home care and home-based care, and it will likely double by 2040 as the population ages, according to the study.
CLEVELAND, April 5, 2013 /PRNewswire/ -- The first-in-human study of the NeuroBlate™ Thermal Therapy System finds that it appears to provide a new, safe and minimally invasive procedure for treating recurrent glioblastoma (GBM), a malignant type of brain tumor. The...
A technology being developed at the Department of Energy's Oak Ridge National Laboratory promises to provide clear images of the brains of children, the elderly, and people with Parkinson's and other diseases without the use of uncomfortable or intrusive restraints.
Researchers in Japan report in the journal Science on Thursday that they could predict images with 60 percent accuracy. First, they watched three subjects as they fell asleep and woke them in early sleep stages to ask them what they saw in their dreams.
InVivo Therapeutics (OTC:NVIV) said the FDA deemed its biopolymer scaffold, designed to treat spinal cord injuries, to be a humanitarian use device. The designation means the InVivo scaffold can seek expedited approval from the FDA for a pivotal trial of the device. HUD-based exemptions cover devices aimed at treating rare diseases and health problems, so-called "orphan" conditions.
Advanced Brain Monitoring Launches InsomniCare, a Cloud-Based, At-Home Technology to Improve Wellness, Productivity, and Workplace Safety for Millions of Insomnia SufferersApril 3, 2013 8:00 am | by The Associated Press | News | Comments
CARLSBAD, Calif.--(BUSINESS WIRE)--Apr 3, 2013--Advanced Brain Monitoring, Inc., a medical device company focused on improving healthcare for patients suffering from sleep and neurological disorders, announced today the launch of InsomniCare SM, an integrated cloud-based system, used at home,...
A plan to map the activity of entire brain regions down to the level of indvidual neurons got its official nod from the White House on Tuesday when President Obama announced his budget will request $100 million in funding for the project in 2014.